Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2024 08:30 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program

BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies...
June 20, 2024 12:09 ET | Source: American Association of Colleges of Osteopathic Medicine

99 Percent of Osteopathic Medical Students Secure Residency Positions

Bethesda, MD, June 20, 2024 (GLOBE NEWSWIRE) -- Today, the American Association of Colleges of Osteopathic Medicine (AACOM) proudly announces that a record-high 8,117 graduating osteopathic medical...
June 13, 2024 07:00 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin
June 11, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology

DENVER, June 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
June 10, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members have joined its Board of Directors. Two new directors,...
June 07, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation

DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
June 06, 2024 16:05 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024

DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
June 06, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical Announces 25-for-1 Reverse Stock Split

DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
May 22, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility

SCD’s ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transplantation Direct DENVER, May 22, 2024 (GLOBE...
May 20, 2024 07:00 ET | Source: Global-e Online Ltd

Global-e Reports First Quarter 2024 Results

PETAH-TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, today reported its financial results for the...